<DOC>
	<DOCNO>NCT00657917</DOCNO>
	<brief_summary>The primary objective protocol treat laboratory confirm cutaneous leishmaniasis WR 279,396 military health care beneficiary . In study `` cutaneous leishmaniasis '' define Old World Leishmaniasis acquire Southwest Central Asia/Middle East .</brief_summary>
	<brief_title>Topical Treatment Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396</brief_title>
	<detailed_description>Up 10 volunteer , military health care beneficiary , diagnosis Old World cutaneous leishmaniasis fail pentavalent antimony eligible treated pentavalent antimony , treat WR 279,396 ( topical paromomycin-gentamicin-AQIC ) twice day 20 day . Primary endpoint appearance complete epithelialization skin lesion Day 50+/-2 week , estimate 50 % -99 % re-epithelialization Day 50+/-2 week follow complete epithelialization Day 100+/-2 week , category without relapse Day 180+/-30 day . Efficacy evaluate clinical appearance assess study investigator document photographs treat skin lesion . Toxicity evaluate local adverse reaction laboratory sign systemic toxicity .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Cutaneous</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Paromomycin</mesh_term>
	<criteria>Parasitologically confirm , primarily ulcerative , Old World CL , patient either fail pentavalent antimony treatment , ineligible pentavalent antimony therapy . Military health care beneficiary 18 year age great , unless active military case , 17 year minimum age Proven parasitological diagnosis culture , PCR microscopy least one skin lesion Lesions primarily ulcerative ( i.e. , verrucous nodular ) Written inform consent participate protocol Negative pregnancy test within 72 hour start protocol Agrees take precaution become pregnant father child least two month completion treatment WR 279,396 Cutaneous leishmaniasis acquire Southwest Central Asia/Middle East* Inadequate response treatment pentavalent antimony medical condition precludes use pentavalent antimony Drug intolerance : history know suspected hypersensitivity idiosyncratic reaction aminoglycosides patient leishmanial lesion mucosal surface Presence sign symptoms peripheral neuropathic myasthenia gravis , neuromuscular block Routinely take nephrotoxic ototoxic medication Disseminated disease define clinically significant subcutaneous nodule lymphatic drainage tract skin lesion regional adenopathy &gt; 1 cm Abnormal Romberg test baseline Clinically significant medical problem kidney liver determine history follow laboratory study : Kidney : Creatinine &gt; 2x upper limit normal Liver : ASTor ALT &gt; 4x upper limit fo normal This include `` L. major , '' `` L. tropica , '' `` L. infantum '' 98 % case U.S. military 20022004 `` L. major '' An inadequate response treatment pentavalent antimony include patient show little improvement 1520 day treatment course , initially epithelialize later show sign breakdown/ ulceration develop new lesion . In general , initial treatment response , would recommend wait approximately two month pentavalent antimony lesion epithelialized time , consideration therapy advise .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>leishmaniasis</keyword>
	<keyword>cutaneous</keyword>
	<keyword>Old World</keyword>
	<keyword>Leishmania major</keyword>
	<keyword>Treatment</keyword>
</DOC>